Mahabala: Benefits, Evidence & Safety

TL;DR

Mahabala (Sida rhombifolia) is a Malvaceae shrub whose roots the Ayurvedic Pharmacopoeia lists among the Bala tonic group. Animal and in-vitro studies suggest anti-inflammatory, liver-protective, and blood-sugar-lowering effects, but there are no human trials. Safety data in people is essentially absent, so treat all claims as preliminary.

(47 words. Sources: Ayurvedic Pharmacopoeia of India Pt. I Vol. III; Sulaiman et al. 2008, animal study; Galeano et al. 2025, animal study.)

What it is

Mahabala is the dried root of Sida rhombifolia Linn. (family Malvaceae), an erect under-shrub found on roadsides and wasteland across tropical India and more than 70 countries (Ayurvedic Pharmacopoeia of India, Part I, Volume III, monograph 51; Sida genus review, Plants 2025). Its Sanskrit name means "great strength." The plant's leaves, stems, and roots contain phenols, flavonoids, alkaloids, saponins, and tannins (Sida review). Do not confuse it with Bala (Sida cordifolia), its better-known relative; the two are distinct species in the same genus.

Traditional use

Mahabala belongs to the Bala group of Ayurvedic tonics, Bala, Atibala, Nagabala, and Mahabala, described in Nighantu literature as balya (strength-promoting) drugs (review of Bala in Ayurveda). In classical practice the Sida roots are regarded as cooling, astringent tonics, and Bala-group roots appear in formulations for nervous debility, urinary disorders, and general weakness. These are traditional classifications, not clinical proof: the laboratory evidence is assessed separately below.

What modern research says

Inflammation and pain (animal studies)

In a carrageenan-induced rat paw-edema model, ethanolic leaf extract of S. rhombifolia at 30, 100, and 300 mg/kg (given intraperitoneally) produced significant dose-dependent reductions in swelling, with parallel pain-relieving effects in abdominal-constriction and hot-plate tests in mice (Sulaiman et al., Research Journal of Pharmacology 2008;2:13–16). A separate Swiss-mouse study found an acetone–water extract (100–400 mg/kg) significantly inhibited both carrageenan paw edema and croton-oil ear edema (IJPSR). These are animal findings; no human anti-inflammatory trials exist.

Liver and kidney protection (animal studies)

In mice with acetaminophen-induced liver injury, a methanolic aerial-parts extract (50–200 mg/kg) significantly lowered the liver enzymes GPT and ALP, and in gentamicin-induced kidney injury it lowered creatinine, performing comparably to the reference compound silymarin (Vitae, 2025). Separately, in rats with diet- and chemical-induced non-alcoholic fatty liver disease, leaf extract at 200–400 mg/kg reduced the inflammatory marker TNF-α, the fat-synthesis regulator SREBP-1, and the overall liver-damage score (Indonesian biomedical journal, 2026). Both studies are in rodents, not people.

Blood sugar (weak evidence)

A review of S. rhombifolia pharmacology notes a reported study in which an aqueous leaf extract showed blood-sugar-lowering and lipid-lowering effects in normal and streptozotocin-induced diabetic rats (Natural Products Chemistry & Research review). This is secondhand reporting of a single animal study: weak evidence, and no human data exists.

What the evidence does not support (yet)

There are no randomized human trials of Mahabala for any condition. Claims about strength, immunity, arthritis, or neurological benefit rest on traditional use and early animal work, not on tested effects in people.

Safety & contraindications

In the mouse study above, a single oral dose of the methanolic extract up to 2,000 mg/kg caused no deaths or abnormal behavior, and a second study found no signs of toxicity in rats at 2,000–5,000 mg/kg (Vitae, 2025; Journal of Biosciences and Medicines, 2025). But these are acute animal-toxicity findings, not human safety data, there are no human safety trials, no pregnancy data, and no interaction studies, so safety data is limited, talk to a clinician before use, especially if pregnant, breastfeeding, or taking medication.

FAQs

What is Mahabala in Ayurveda?

Mahabala is the Sanskrit name for Sida rhombifolia Linn., a Malvaceae under-shrub whose dried root is an official drug in the Ayurvedic Pharmacopoeia of India (Part I, Volume III, monograph 51). It belongs to the Bala group of traditional tonics (balya drugs) used for strength and debility: a traditional classification, not a proven clinical effect.

Is Mahabala the same as Bala?

No. Bala is Sida cordifolia, while Mahabala is Sida rhombifolia: distinct species in the same genus. Classical Nighantu literature groups them with Atibala and Nagabala as related "Bala" tonics, but their pharmacopoeial identities and monographs are separate. Always verify the botanical name on any product label.

Does Mahabala reduce inflammation?

In animals, yes, preliminarily: ethanolic and acetone–water extracts reduced carrageenan-induced paw swelling and showed pain-relieving effects in rodent models (Sulaiman et al., Research Journal of Pharmacology 2008;2:13–16; IJPSR). There are no human trials, so an anti-inflammatory effect in people is unproven. Human studies would be needed before any therapeutic claim can be made.

Can Mahabala protect the liver?

Rodent studies suggest it might: a methanolic extract lowered liver-injury enzymes in acetaminophen-poisoned mice, and a leaf extract improved fatty-liver markers in rats (Vitae, 2025; 2026 NAFLD study). These are animal results only; no human liver studies exist. More research, especially in humans, is needed before any conclusion.

Does Mahabala lower blood sugar?

Only one reported animal study suggests this: an aqueous leaf extract lowered blood sugar in diabetic rats (review). The evidence is weak and secondhand, and there are no human data; it should not be used as a diabetes treatment.

Is Mahabala safe?

Animal studies found no acute toxicity at high single doses, but there are no human safety trials, no pregnancy data, and no drug-interaction studies. Human safety is essentially unstudied: talk to a qualified clinician before using it. Do not use it during pregnancy or while breastfeeding without medical advice.

Sources

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.